Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
Clinical trial NCT01415882 · COMPLETED
Trial details
- NCT number
- NCT01415882
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-31
- Primary completion
- 2023-04-21
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.